← Back to Screener
Staar Surgical Co (STAA)
Price$24.62
Favorite Metrics
Price vs S&P 500 (26W)-10.67%
Price vs S&P 500 (4W)27.28%
Market Capitalization$1.21B
All Metrics
P/CF (Annual)57.84x
Book Value / Share (Quarterly)$6.97
P/TBV (Annual)3.74x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-5.57%
Cash Flow / Share (Quarterly)$-0.81
Price vs S&P 500 (YTD)4.46%
Gross Margin (TTM)76.19%
Net Profit Margin (TTM)-33.60%
EPS (TTM)$-1.63
10-Day Avg Trading Volume1.63M
EPS Excl Extra (TTM)$-1.63
Revenue Growth (5Y)7.93%
EPS (Annual)$-1.62
ROI (Annual)-23.37%
Gross Margin (Annual)76.19%
Net Profit Margin (5Y Avg)-1.83%
Cash / Share (Quarterly)$3.80
Revenue Growth QoQ (YoY)6.93%
ROA (Last FY)-17.81%
Revenue Growth TTM (YoY)-32.42%
EBITD / Share (TTM)$-1.63
ROE (5Y Avg)-0.36%
Operating Margin (TTM)-38.30%
Cash Flow / Share (Annual)$-0.81
P/B Ratio3.51x
P/B Ratio (Quarterly)3.41x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)4.40x
Net Interest Coverage (TTM)11.43x
ROA (TTM)-17.85%
EPS Growth QoQ (YoY)-12.41%
EV / EBITDA (TTM)32.00x
EPS Incl Extra (Annual)$-1.62
Current Ratio (Annual)4.55x
Quick Ratio (Quarterly)3.54x
3-Month Avg Trading Volume1.54M
52-Week Price Return43.20%
EV / Free Cash Flow (Annual)57.39x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.35
P/S Ratio (Annual)5.04x
Asset Turnover (Annual)0.53x
52-Week High$30.81
Operating Margin (5Y Avg)-0.75%
EPS Excl Extra (Annual)$-1.62
CapEx CAGR (5Y)-7.08%
Tangible BV CAGR (5Y)14.46%
26-Week Price Return-6.68%
Quick Ratio (Annual)3.54x
13-Week Price Return12.36%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.55x
Enterprise Value$1,053.971
Revenue / Share Growth (5Y)7.24%
Asset Turnover (TTM)0.53x
Book Value / Share Growth (5Y)10.39%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.90x
Pretax Margin (Annual)-34.36%
Cash / Share (Annual)$3.80
3-Month Return Std Dev66.90%
Gross Margin (5Y Avg)77.38%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)29.74%
ROE (Last FY)-23.37%
Net Interest Coverage (Annual)-3.18x
EPS Basic Excl Extra (Annual)$-1.62
P/FCF (TTM)676.64x
Receivables Turnover (TTM)2.80x
EV / Free Cash Flow (TTM)261.09x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.63
Receivables Turnover (Annual)3.64x
ROI (TTM)-23.24%
P/S Ratio (TTM)5.04x
Pretax Margin (5Y Avg)0.56%
Revenue / Share (Annual)$4.83
Tangible BV / Share (Annual)$6.35
Forward P/E63.32x
Price vs S&P 500 (52W)13.37%
Year-to-Date Return7.10%
5-Day Price Return-1.90%
EPS Normalized (Annual)$-1.62
ROA (5Y Avg)-0.19%
Net Profit Margin (Annual)-33.60%
Month-to-Date Return32.25%
Cash Flow / Share (TTM)$0.50
EBITD / Share (Annual)$-1.70
Operating Margin (Annual)-38.30%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-0.36%
LT Debt / Equity (Quarterly)0.15x
EPS Basic Excl Extra (TTM)$-1.63
P/TBV (Quarterly)3.74x
P/B Ratio (Annual)3.41x
Inventory Turnover (TTM)1.29x
Pretax Margin (TTM)-34.36%
Book Value / Share (Annual)$6.97
Price vs S&P 500 (13W)11.67%
Beta1.10x
P/FCF (Annual)68.55x
Revenue / Share (TTM)$4.81
ROE (TTM)-23.24%
52-Week Low$15.59
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.64
2.60
2.63
3.47
Industry Peers — Ophthalmic Goods(5)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|
STAAStaar Surgical Co | — | -23.24% | 7.93% | — | $24.62 |
COOThe Cooper Companies, Inc. Common Stock | 36.30x | 4.83% | 10.98% | 0.02% | $69.38 |
BLCOBausch + Lomb Corporation | — | -5.61% | 8.38% | — | $16.59 |
WRBYWarby Parker Inc. | 1768.44x | 0.45% | 17.24% | — | $23.17 |
EYENational Vision Holdings, Inc. Common Stock | 67.55x | 3.47% | 3.03% | — | $24.87 |
RXSTRxSight, Inc. Common Stock | — | -14.05% | 55.73% | — | $7.38 |
About
STAAR Surgical Co manufactures Implantable Collamer Lenses (ICL) and delivery systems for refractive eye surgery. The company derives nearly all revenue from ICL sales, which are used to correct myopia and other refractive errors. A substantial portion of revenues comes from international markets.